Latest Share Chat

REMOVE ADS

SLN.L Share News (SLN)

SLN.L Information

There is currently no data for SLN

REMOVE ADS

SLN.L News

Silence Therapeutics Reappoints Ross As Chair; Changes Non-Execs

LONDON (Alliance News) - Silence Therapeutics PLC said Thursday it had reappointed Iain Ross as chair of the genetic medicines firm with immediate eff...

Silence Therapeutics Interim Finance Chief Quinn Appointed Permanently

LONDON (Alliance News) - Silence Therapeutics PLC said on Thursday Interim Chief Financial Officer Rob Quinn has been promoted to the role on a perman...

Silence Therapeutics makes Rob Quinn permanent CFO

(Sharecast News) - Biotechnology company Silence Therapeutics said it had appointed Rob Quinn to take over as its full-time chief financial officer, e...

Silence Therapeutics Interim Chair Departs, New Head Of R&D Joins

LONDON (Alliance News) - Silence Therapeutics PLC on Tuesday reported a number of changes to its board and operational team, including its interim cha...

Silence Therapeutics Loss Widens After Share Disposal Year Before

LONDON (Alliance News) - Silence Therapeutics PLC on Monday said its loss widened considerably in its most recent year after a gain on the disposal of...

Silence Therapeutics losses widen as it progresses drug candidates

(Sharecast News) - Drug development company Silence Therapeutics announced its unaudited preliminary results for the year ended 31 December on Monday,...

Silence Therapeutics' Lead Candidate Drug Gets Orphan Status In Europe

LONDON (Alliance News) - Silence Therapeutics on Tuesday said its SLN124 main candidate drug has been designated as an orphan drug in Europe for the t...

Silence Therapeutics CFO steps down

(Sharecast News) - Silence Therapeutics chief financial officer David Ellam stepped down from the group with immediate effect on Wednesday.